Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Application entities : Enlivex therapeutics ltd. save search
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ in Patients Receiving CAR T-Cell Therapy
Published: 2023-04-19 (Crawled : 13:00) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 2.76%
H: 2.35%
C: -2.01%
patent t-cell application therapy
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Use of Allocetra™ to Prevent Cytokine Release Syndrome in Patients Receiving CAR T Cell Therapy
Published: 2022-09-06 (Crawled : 13:00) - globenewswire.com
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 4.46%
H: 0.0%
C: -7.24%
patent application therapy
Enlivex Receives Notice of Allowance for Japanese Patent Application Covering Allocetra Derived from Pooled Donor Cells
Published: 2022-08-29 (Crawled : 13:20) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: -3.84%
H: 5.63%
C: -0.18%
patent application
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering Methods of Treating Sepsis with Allocetra™
Published: 2022-08-03 (Crawled : 12:20) - globenewswire.com
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 1.12%
H: 7.15%
C: 5.31%
patent application
Enlivex to Detail the Application of its Innovative Macrophage Reprogramming Cell Therapy to Unmet Needs in Oncology at the 11th Annual LifeSci Partners Corporate Access Event
Published: 2022-01-03 (Crawled : 15:00) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 0.8%
H: 6.03%
C: 5.71%
application cel therapy annual lifesci
Enlivex Receives Notice of Allowance for U.S. Patent Application Covering the Treatment of Sepsis Patients with Allocetra
Published: 2021-12-06 (Crawled : 15:00) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 6.31%
H: 0.0%
C: 0.0%
treatment application patent
Enlivex Receives Notice of Allowance for Israeli Patent Application Covering Allocetra Derived from Pooled Donor Cells
Published: 2021-10-05 (Crawled : 14:15) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 0.0%
H: 1.23%
C: -1.13%
israel patent application
Enlivex Receives Notice of Allowance for Japanese Patent Application Covering the use of Allocetra in Combination with CAR-T Therapies
Published: 2021-03-08 (Crawled : 15:00) - biospace.com/
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 6.16%
H: 0.0%
C: -5.87%
car-t patent therapy application
Enlivex Receives Notice of Allowance for Chinese Patent Application Covering Allocetra Immunotherapy
Published: 2021-02-22 (Crawled : 13:03) - globenewswire.com
ENLV | News | $1.27 -3.79% -3.13% 380
|
Health Technology
|
| O: 1.34%
H: 1.87%
C: -11.29%
chinese immunotherapy therapy patent application
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.